Komori
Changes in Officers4569KYORIN Pharmaceutical Co.,Ltd.Pharmaceuticals

Notice of Personnel Changes at KYORIN Pharmaceutical Co.,Ltd.

Effective 1 April 2026, a personnel change will be implemented under which Saeki Satoshi (佐伯 訓)'s position as department head will change to General Manager assigned to the Clinical Development Center, Drug Discovery Division.

Worth reading
14Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Incoming appointee

1 item
Scheduled Appointment Date1 April 2026
Saeki Satoshi (佐伯 訓)
New positionGeneral Manager assigned to the Clinical Development Center, Drug Discovery Division
Who is moving to which position
ItemDetails
Scheduled Appointment Date1 April 2026
Name of appointeeSaeki Satoshi (佐伯 訓)
Appointee's new positionGeneral Manager assigned to the Clinical Development Center, Drug Discovery Division
Items this document does not state (18)
Resolution dateDate of departureAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The reason for the personnel change is not stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Personnel Changes at KYORIN Pharmaceutical Co.,Ltd. | KYORIN Pharmaceutical Co.,Ltd. (4569) timely disclosure | Komori